METHOD FOR CORRECTING STRESS-INDUCED HEMOSTASIS SYSTEM CHANGES CAUSED BY SURGICAL INTERVENTIONS IN METABOLIC SYNDROME CASES Russian patent published in 2007 - IPC A61K31/352 A61K31/155 A61K31/727 A61K38/24 A61P7/02 

FIELD: medicine.

SUBSTANCE: method involves administering Thyroxin at a dose of 50 mg/day in a combination with Metformin at a dose of 500 mg/day, Detralex at a dose of 800 mg/day within a month before forthcoming operation to patients. Low molecular weight heparin is subcutaneously introduced two hours before surgical intervention. Hydroxyethylized starch infusion is carried out at a dose of 0.5-1.0 ml/kg during operation. Low molecular weight heparin is subcutaneously introduced 7 days long after the surgical intervention.

EFFECT: enhanced effectiveness of treatment; prevented thrombogenetic complications and hemodynamic instability; improved metabolic processes in blood platelets, blood vessel walls; decreased thrombophilic orientations of hemostasis system.

2 tbl